Dr. Hoffman is responsible for the development of commercialization opportunities for LA BioMed’s intellectual properties, capabilities and expertise.
Prior to LA BioMed, Dr. Hoffman held senior management roles (COO, CBO, VP) in business, corporate, science, and intellectual property development for biotechnology, healthcare data, medical device, and consumer product companies. As part of those efforts Dr. Hoffman drafted, and assisted in the prosecution of, over 70 patents. Most recently, he was part of the founding team at Advera Health Analytics where he developed and helped monetize big data platforms that provide real world side effect data on all FDA approved drugs.
Dr. Hoffman is a native San Diegan who earned both his B.S. in Biology and Ph.D. in Neuroscience from UC Irvine in the laboratory of Dr. Gary Lynch. His research at Irvine focused on the molecular basis of learning and memory with an emphasis on how neural cell adhesion molecules may modulate synaptic architectures.
Agatha is a technology transfer professional with experience in technology portfolio management, patent prosecution and marketing activities. She has hands-on experience in negotiating and managing technology transfer related agreements. Prior to joining LA Biomed, she was a Technology Transfer Liaison at The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc., followed by serving as a Technology Transfer Intern at UCLA Office of Intellectual Property.
Agatha holds a Ph.D. from UCLA in Biomedical Engineering and did her research in Laboratory of Neuro Imaging analyzing human brain images from MRI/DTI to understand how genes influence neuro/physiological anatomy. Prior to attending UCLA , she received a B.S. from Johns Hopkins University in Biomedical Engineering and assisted research involving conformal mapping of cortical surface of human brains at Center for Imaging Science.